Market Research Logo

U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020

U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020

The report segments the U.S. general anesthesia drugs market on the basis of molecule and route of administration. On the basis of molecules, the market is divided into Propofol, Benzodiazepine, Ketamine (S-(+)-Ketamine HCL), and Methohexital Sodium. Propofol is expected to be fastest-growing segment, owing to its greater preference and rapid onset of action.

On the basis of route of administration, the U.S. general anesthesia drugs market is bifurcated into intravenous and inhalational. The intravenous segment is expected to account for the largest share of the U.S. general anesthesia drugs market in 2015. Greater patient compliance and less number of side effects as compared to inhalational anesthetics are driving the growth of this market.

Acquisitions was the most preferred strategy adopted by major industry players in order to increase their market shares and cater to unmet needs.

This report provides insights on the qualitative data, market size, growth of various segments and subsegments, and prominent players in this market. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and government initiatives. The report also provides a company profiles section, which comprises basic views on the key players in the U.S. general anesthesia drugs market and their product portfolios, developments, and strategies adopted to maintain and increase their market shares. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned three strategies (market penetration, competitive assessment, and market entry).

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on product portfolios of the top players in the U.S. general anesthesia drugs market. The report analyzes the U.S. general anesthesia drugs market by molecule and mode of administration.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the U.S. general anesthesia drugs market

Market Entry: Comprehensive information about business strategies for entering the U.S. general anesthesia drugs market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • KEY INDUSTRY INSIGHTS
    • ASSUMPTIONS FOR THE STUDY
  • MARKET OVERVIEW
    • MARKET ANALYSIS
    • MARKET DYNAMICS
      • DRIVERS
        • Table AGEING POPULATION AND RISING NUMBER OF EMERGENCY SURGERIES TO DRIVE THE U.S. GENERAL ANESTHESIA DRUGS MARKET
      • RESTAINTS
        • Table SIDE EFFECTS OF GENERAL ANESTHETICS AND REGULATORY ISSUES TO HINDER MARKET GROWTH
      • OPPORTUNITIES
        • Table PATENT EXPIRY OF LUSEDRA OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR THE MARKET PLAYERS
    • MARKET SIZE
      • HISTORICAL MARKET TRENDS, 2010-2014
      • MARKET FORECASTS, 2015-2020
  • DISTRIBUTION STRUCTURE
    • U.S. KETAMINE MARKET: DISTRIBUTION STRUCTURE
      • Table U.S.: KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2010-2014 (USD MILLION)
      • Table U.S.: KETAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2015-2020 (USD MILLION)
    • U.S. KETAMINE MARKET, 2010-2014
      • U.S. KETAMINE MARKET, BY MANUFACTURER
        • Table U.S.: KETAMINE MARKET SIZE, BY MANUFACTURER, 2010-2014 (USD MILLION)
        • Table U.S.: KETAMINE MARKET SIZE, BY MANUFACTURER, 2010-2014 (KILOGRAM)
        • Table U.S.: KETAMINE MARKET SIZE, BY MANUFACTURER, 2015-2020 (USD MILLION)
        • Table U.S.: KETAMINE MARKET SIZE, BY MANUFACTURER, 2015-2020 (KILOGRAM)
      • U.S. KETAMINE MARKET, BY DISTRIBUTION CHANNEL
        • Table U.S.: KETAMINE MARKET SIZE, BY GPO, 2010-2014 (USD MILLION)
        • Table U.S.: KETAMINE MARKET SIZE, BY GPO, 2010-2014 (KILOGRAM)
        • Table U.S. KETAMINE MARKET SIZE, BY GPO, 2015-2020 (USD MILLION)
        • Table U.S.: KETAMINE MARKET SIZE, BY GPO, 2015-2020 (KILOGRAM)
        • Table U.S.: KETAMINE MARKET SIZE, BY DISTRIBUTOR, 2010-2014 (USD MILLION)
        • Table U.S.: KETAMINE MARKET SIZE, BY DISTRIBUTOR, 2010-2014 (KILOGRAM)
        • Table U.S.: KETAMINE MARKET SIZE, BY DISTRIBUTOR, 2015-2020 (USD MILLION)
        • Table U.S.: KETAMINE MARKET SIZE, BY DISTRIBUTOR, 2015-2020 (KILOGRAM)
    • MAJOR LEGAL TRENDS FOR CONTROLLED SUBSTANCES
      • COMPLIANCE ASSOCIATED WITH MANUFACTURING OF NARCOTICS IN THE U.S.
      • COMPLIANCE ASSOCIATED WITH VENDORS OF NARCOTICS IN THE U.S.
    • PRODUCT CATEGORY ENUMERATION
      • KETAMINE
      • OTHER BRANDS
    • MARKET SHARE, 2010-2014
      • MARKET SHARE, BY KEY PRODUCT
      • MARKET SHARE, BY KEY PLAYER
  • PRODUCT ANALYSIS
    • ANESTHESIA DRUGS MARKET SEGMENTATION IN THE U.S.
      • Table ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2010-2014 (USD MILLION)
      • Table ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2015-2020 (USD MILLION)
      • Table U.S. ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2010-2014 (USD MILLION)
      • Table U.S. ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2015-2020 (USD MILLION)
      • GENERAL ANESTHESIA DRUGS MARKET SEGMENTATION
        • Table U.S. GENERAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2010-2014 (USD MILLION)
    • U.S.: MARKET SHARE, GENERAL ANESTHETICS, 2010-2014
      • MAJOR BRANDS/MOLECULES
        • Table KETAMINE: MAJOR COMPETITOR BRANDS & MOLECULES
    • COMPETITION IN THE U.S.
      • KEY COMPETITORS
        • Table U.S. GENERAL INTRAVENOUS ANESTHESIA DRUGS MARKET SIZE, BY MOLECULE, 2010-2014 (USD MILLION)
        • Table U.S. GENERAL INTRAVENOUS ANESTHESIA DRUGS MARKET SIZE, BY MOLECULE, 2015-2020 (USD MILLION)
      • PRICE
        • Table KETAMINE: PRICE, 2012 (USD)
        • Table METHOHEXITAL SODIUM PRICE, 2012 (USD)
        • Table FOSPROPOFOL DISODIUM PRICE, 2012 (USD)
        • Table PENTOBARBITAL SODIUM PRICE, 2012 (USD)
        • Table PROPOFOL PRICE, 2012 (USD)
        • Table MIDAZOLAM PRICE, 2012 (USD)
        • Table ETOMIDATE SODIUM PRICE, 2012 (USD)
        • Table TOTAL PER STUDY COST OF CLINICAL TRIALS, BY PHASE, (USD MILLION)
        • Table KETAMINE PRICE, 2012 (USD)
      • MAJOR BRANDS
        • Table GENERAL INTRAVENOUS ANESTHESIA DRUGS: USAGE TRENDS
        • Table U.S.: TOP ABUSED PRESCRIPTION DRUGS, 2013
    • LOCAL SALES PRICE
      • MANUFACTURER PRICE OF KETAMINE
        • Table MANUFACTURER PRICE OF KETAMINE, 2012
    • POTENTIAL BUYERS IN THE U.S.
      • POTENTIAL BUYERS, BY STATE
        • Table GROUP PURCHASING ORGANIZATIONS, BY STATE
        • Table DISTRIBUTORS, BY STATE
  • U.S. GENERAL ANESTHESIA DRUGS MARKET: KEY INFORMATION
    • IMPORT & EXPORT SYSTEMS IN THE U.S.
      • IMPORT OF CONTROLLED SUBSTANCES
      • EXPORT OF CONTROLLED SUBSTANCES
      • BASED ON TARIFFS
        • Table HARMONIZED TARIFF SCHEDULE FOR ANESTHESIA DRUGS
        • Table ANESTHESIA MOLECULES: CHEMICAL ABSTRACTS SERVICES (CAS) NUMBERS
      • BASED ON TRANSPORT
      • CUSTOMS CLEARANCE
      • NON-TARIFF BARRIERS
        • Table REGULATORY REQUIREMENTS FOR CONTROLLED SUBSTANCES
    • TOP RELATED EXHIBITIONS
      • Table ANESTHESIA EXHIBITIONS
    • DESCRIPTION OF POTENTIAL BUYERS
      • Table POTENTIAL GROUP PURCHASING ORGANIZATIONS
      • Table POTENTIAL DISTRIBUTORS
  • STRATEGIC RECOMMENDATIONS FOR ENTERING THE U.S. GENERAL ANESTHESIA DRUGS MARKET
  • COMPANY PROFILES
    • INTRODUCTION
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ASTRAZENECA PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • BAXTER INTERNATIONAL INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • HIKMA PHARMACEUTICALS PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MYLAN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • EISAI CO., LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • FRESENIUS SE & CO. KGAA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • HOSPIRA, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • PAR PHARMACEUTICAL COMPANIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • REGULATIONS FOR CONTROLLED SUBSTANCES IN THE U.S.
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report